• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

跟踪 SARS-CoV-2 疫苗研发管线。

Keeping track of the SARS-CoV-2 vaccine pipeline.

机构信息

The Vaccine Centre, London School of Hygiene & Tropical Medicine, London, UK.

Vaccines & Immunity Theme, MRC Unit, The Gambia at the London School of Hygiene & Tropical Medicine, London, UK.

出版信息

Nat Rev Immunol. 2020 Nov;20(11):650. doi: 10.1038/s41577-020-00455-1.

DOI:10.1038/s41577-020-00455-1
PMID:32989290
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7521571/
Abstract

This Web Watch introduces the VaC tracker, a web resource that features an overview of the COVID-19 ‘vaccine landscape’, a clinical trials database and a ‘living review’ that distils the results of vaccine trials as they become available.

摘要

本网络观察介绍了 VaC 追踪器，这是一个网络资源，提供了 COVID-19“疫苗领域”的概述、临床试验数据库以及“实时评论”，随着疫苗试验结果的公布，对其进行提炼。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c46d/7521571/6dd191ef9cfe/41577_2020_455_Figa_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c46d/7521571/6dd191ef9cfe/41577_2020_455_Figa_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c46d/7521571/6dd191ef9cfe/41577_2020_455_Figa_HTML.jpg

相似文献

1
Keeping track of the SARS-CoV-2 vaccine pipeline. 跟踪 SARS-CoV-2 疫苗研发管线。
Nat Rev Immunol. 2020 Nov;20(11):650. doi: 10.1038/s41577-020-00455-1.
2
COVID-19 vaccine trials: Duty of care and standard of prevention considerations.2019冠状病毒病疫苗试验：注意义务与预防标准考量
Vaccine. 2020 Nov 10;38(48):7578-7580. doi: 10.1016/j.vaccine.2020.10.012. Epub 2020 Oct 9.
3
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines.布莱顿协作组织（ Brighton Collaboration ）用于收集灭活病毒疫苗的获益-风险评估关键信息的标准化模板。
Vaccine. 2020 Sep 3;38(39):6184-6189. doi: 10.1016/j.vaccine.2020.07.028. Epub 2020 Jul 31.
4
Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry.探索新冠疫苗加速反应中的不确定性和风险：来自制药行业的观点。
Vaccine. 2020 Nov 10;38(48):7588-7595. doi: 10.1016/j.vaccine.2020.10.034. Epub 2020 Oct 13.
5
The Race to Develop a COVID-19 Vaccine.新冠疫苗研发竞赛。
Am J Nurs. 2020 Oct;120(10):14-15. doi: 10.1097/01.NAJ.0000718556.85319.00.
6
COVID-19: Small-Molecule Clinical Trials Landscape.新冠病毒病（COVID-19）：小分子药物临床试验全景
Curr Top Med Chem. 2020;20(18):1577-1580. doi: 10.2174/156802662018200703154334.
7
COVID-19 Vaccine: A comprehensive status report.新型冠状病毒肺炎疫苗：全面现状报告。
Virus Res. 2020 Oct 15;288:198114. doi: 10.1016/j.virusres.2020.198114. Epub 2020 Aug 13.
8
COVID-19 and Bacillus Calmette-Guérin: What is the Link?新型冠状病毒肺炎与卡介苗：有何关联？
Eur Urol Oncol. 2020 Jun;3(3):259-261. doi: 10.1016/j.euo.2020.04.001. Epub 2020 Apr 13.
9
All eyes on a hurdle race for a SARS-CoV-2 vaccine.所有人的目光都聚焦在新冠病毒疫苗的一场障碍赛上。
Nature. 2020 Oct;586(7830):501-502. doi: 10.1038/d41586-020-02926-w.
10
Understanding COVID-19 vaccine efficacy.了解新冠病毒疫苗的效力。
Science. 2020 Nov 13;370(6518):763-765. doi: 10.1126/science.abe5938. Epub 2020 Oct 21.

引用本文的文献

1
Combined prevention and treatment measures are essential to control nosocomial infections during the COVID-19 pandemic.在新冠疫情期间，采取综合防治措施对于控制医院感染至关重要。
World J Virol. 2024 Jun 25;13(2):91286. doi: 10.5501/wjv.v13.i2.91286.
2
The Equal Neutralizing Effectiveness of BNT162b2, ChAdOx1 nCoV-19, and Sputnik V Vaccines in the Palestinian Population.BNT162b2、ChAdOx1 nCoV-19和卫星五号疫苗在巴勒斯坦人群中的中和效力相当
Vaccines (Basel). 2024 May 3;12(5):493. doi: 10.3390/vaccines12050493.
3
FcRIIa - dependent platelet activation identified in COVID-19 vaccine-induced immune thrombotic thrombocytopenia-, heparin-induced thrombocytopenia, streptokinase- and anisoylated plasminogen-streptokinase activator complex-induced platelet activation.
在新冠疫苗诱导的免疫性血栓性血小板减少症、肝素诱导的血小板减少症、链激酶和酰化纤溶酶原-链激酶激活剂复合物诱导的血小板激活中发现的FcRIIa依赖性血小板激活。
Front Cardiovasc Med. 2023 Nov 15;10:1282637. doi: 10.3389/fcvm.2023.1282637. eCollection 2023.
4
Dynamical modelling of viral infection and cooperative immune protection in COVID-19 patients.COVID-19 患者中病毒感染和协同免疫保护的动力学建模。
PLoS Comput Biol. 2023 Sep 1;19(9):e1011383. doi: 10.1371/journal.pcbi.1011383. eCollection 2023 Sep.
5
Comparison of Humoral Antibody Responses and Seroconversion Rates between Two Homologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination in Patients Undergoing Maintenance Hemodialysis.维持性血液透析患者中两种同源ChAdOx1 nCoV-19疫苗和mRNA-1273疫苗接种后的体液抗体反应及血清转化率比较
Vaccines (Basel). 2023 Jun 27;11(7):1161. doi: 10.3390/vaccines11071161.
6
SARS-CoV-2 Vaccines, Vaccine Development Technologies, and Significant Efforts in Vaccine Development during the Pandemic: The Lessons Learned Might Help to Fight against the Next Pandemic.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗、疫苗开发技术以及疫情期间疫苗开发的重大努力：吸取的经验教训可能有助于抗击下一次大流行。
Vaccines (Basel). 2023 Mar 17;11(3):682. doi: 10.3390/vaccines11030682.
7
The Streptococcus pyogenes vaccine landscape.化脓性链球菌疫苗的情况。
NPJ Vaccines. 2023 Feb 14;8(1):16. doi: 10.1038/s41541-023-00609-x.
8
Identifying COVID-19 optimal vaccine dose using mathematical immunostimulation/immunodynamic modelling.利用数学免疫刺激/免疫动力学模型确定 COVID-19 的最佳疫苗剂量。
Vaccine. 2022 Nov 22;40(49):7032-7041. doi: 10.1016/j.vaccine.2022.10.012. Epub 2022 Oct 17.
9
Public attitudes on social media toward vaccination before and during the COVID-19 pandemic.社交媒体上公众对 COVID-19 大流行前后疫苗接种的态度。
Hum Vaccin Immunother. 2022 Nov 30;18(6):2101835. doi: 10.1080/21645515.2022.2101835. Epub 2022 Aug 3.
10
Conjugation with 8-arm PEG and CRM enhances the immunogenicity of SARS-CoV-2 ORF8 protein.与 8 臂聚乙二醇（PEG）和 CRM 缀合可增强 SARS-CoV-2 ORF8 蛋白的免疫原性。
Int Immunopharmacol. 2022 Aug;109:108922. doi: 10.1016/j.intimp.2022.108922. Epub 2022 Jun 6.